Menu Menu

RNAZ    Transcode Therapeutics Inc    1829635    
Income Statement
Net Income rnaz-20240930x10q -2,321,387

Balance Sheet
Current Assets 3,612,589
Assets 3,936,105
Current Liabilities 2,283,940
Liabilities 2,283,940
Equity 1,652,165
Shares Out 17,266,000

Cash Flow Statement
Operating Cash Flow -10,189,610
Investing Cash Flow -21,261

Market Analysis
Market Cap 5,196,175
Price 3.35
BVPS 0.10
PB 35.53
EPS -75.48
FCF -10,210,871
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Find a discrepancy? The most accurate way to find company fundamental data is to view RNAZ documents filed with the SEC.


RNAZ Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas